UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers

Cancer cell, 2018-10, Vol.34 (4), p.549-560.e9

2018

Link zum Volltext

Verfügbarkeit prüfen

Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatment

Nature communications, 2019-02, Vol.10 (1), p.733-17, Article 733

2019

Link zum Volltext

Verfügbarkeit prüfen

Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry

PLoS genetics, 2020-02, Vol.16 (2), p.e1008641-e1008641

2020

Link zum Volltext

Verfügbarkeit prüfen

DLL3-guided therapies in small-cell lung cancer: from antibody-drug conjugate to precision immunotherapy and radioimmunotherapy

Molecular cancer, 2024-05, Vol.23 (1), p.97-5, Article 97

2024

Link zum Volltext

Verfügbarkeit prüfen

Siglec-6 as a therapeutic target for cell migration and adhesion in chronic lymphocytic leukemia

Nature communications, 2024-06, Vol.15 (1), p.5180-20, Article 5180

2024

Link zum Volltext

Verfügbarkeit prüfen

γδ T cells for immunotherapy

Blood, 2018-11, Vol.132 (21), p.2212-2213

Long, Meixiao

2018

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia

Haematologica (Roma), 2021-06, Vol.106 (6), p.1608

2021

Link zum Volltext

Verfügbarkeit prüfen

Systematic Characterization of Recurrent Genomic Alterations in Cyclin-Dependent Kinases Reveals Potential Therapeutic Strategies for Cancer Treatment

Cell reports (Cambridge), 2020-07, Vol.32 (2), p.107884-107884, Article 107884

2020

Link zum Volltext

Verfügbarkeit prüfen

The kinase PDK1 is essential for B-cell receptor mediated survival signaling

PloS one, 2013-02, Vol.8 (2), p.e55378-e55378

2013

Link zum Volltext

Verfügbarkeit prüfen

Nuclear Factor-κB Modulates Regulatory T Cell Development by Directly Regulating Expression of Foxp3 Transcription Factor

Immunity (Cambridge, Mass.), 2009-12, Vol.31 (6), p.921-931

2009

Link zum Volltext

Verfügbarkeit prüfen

Factors Affecting the Cancer Immunotherapeutic Efficacy of T Cell Bispecific Antibodies and Strategies for Improvement

Immunological investigations, 2022-11, Vol.51 (8), p.2176-2214

2022

Link zum Volltext

Verfügbarkeit prüfen

Ibrutinib treatment improves T cell number and function in CLL patients

The Journal of clinical investigation, 2017-08, Vol.127 (8), p.3052-3064

2017

Link zum Volltext

Verfügbarkeit prüfen

CD33‐Targeted Therapies: Beating the Disease or Beaten to Death?

Journal of clinical pharmacology, 2021-01, Vol.61 (1), p.7-17

2021

Link zum Volltext

Verfügbarkeit prüfen

A CD3 humanized mouse model unmasked unique features of T-cell responses to bispecific antibody treatment

Blood advances, 2024-01, Vol.8 (2), p.470-481

2024

Link zum Volltext

Verfügbarkeit prüfen

IκBβ acts to inhibit and activate gene expression during the inflammatory response

Nature (London), 2010-08, Vol.466 (7310), p.1115-1119

2010

Link zum Volltext

Verfügbarkeit prüfen

T Regulatory Cells Maintain Intestinal Homeostasis by Suppressing γδ T Cells

Immunity (Cambridge, Mass.), 2010-11, Vol.33 (5), p.791-803

2010

Link zum Volltext

Verfügbarkeit prüfen

The IKK-neutralizing compound Bay11 kills supereffector CD8 T cells by altering caspase-dependent activation-induced cell death

Journal of leukocyte biology, 2009-01, Vol.85 (1), p.175-185

2009

Link zum Volltext

Verfügbarkeit prüfen

Trial in Progress: Phase 1/2 Study Evaluating the Safety and Efficacy of Iov-2001, an Autologous, Non-Genetically Modified, Polyclonal T-Cell Product, in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Blood, 2021-11, Vol.138 (Supplement 1), p.3846-3846

2021

Link zum Volltext

Verfügbarkeit prüfen

Expansion and Characterization of Iovance Marrow Infiltrating Lymphocytes: A Potential Novel Therapeutic Strategy for the Treatment of Acute Myeloid Leukemia

Blood, 2018-11, Vol.132 (Supplement 1), p.5683-5683

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT244: A Phase 1/2 study evaluating the safety and efficacy of IOV-2001 in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT244-CT244

2021

Link zum Volltext

Verfügbarkeit prüfen

PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression

The Journal of clinical investigation, 2019-01, Vol.129 (1), p.122-136

2019

Link zum Volltext

Verfügbarkeit prüfen

Systematic Pan-Cancer Characterization of Nuclear Receptors Identifies Potential Cancer Biomarkers and Therapeutic Targets

Cancer research (Chicago, Ill.), 2022-01, Vol.82 (1), p.46-59

2022

Link zum Volltext

Verfügbarkeit prüfen

SUSD2 suppresses CD8 + T cell antitumor immunity by targeting IL-2 receptor signaling

Nature immunology, 2022-11, Vol.23 (11), p.1588

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(88)
Dissertationen
(1)

Sprache

Englisch
(89)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(30)
Animals
(20)
Humans
(18)
Mice
(18)
Immunology
(12)
Mice, Transgenic
(10)
Hematology
(9)
Cancer
(8)
Male
(8)
Oncology
(8)
Cd4-Positive T-Lymphocytes - Immunology
(7)
Cell Biology
(7)
Female
(7)
Adoptive Transfer
(6)
Immunotherapy
(6)
Kinases
(6)
Chronic Lymphocytic Leukemia
(5)
Leukemia
(5)
Lymphocytes
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(15)
The Journal Of Immunology
(12)
Immunity
(10)
Blood Advances
(5)
Cancer Research
(5)
Journal Of Clinical Oncology
(5)
Nature
(5)
The Journal Of Clinical Investigation
(4)
Cell Reports
(3)
Biology Of Blood And Marrow Transplantation
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers

Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatment

Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry

DLL3-guided therapies in small-cell lung cancer: from antibody-drug conjugate to precision immunotherapy and radioimmunotherapy

Siglec-6 as a therapeutic target for cell migration and adhesion in chronic lymphocytic leukemia

γδ T cells for immunotherapy

Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia

Systematic Characterization of Recurrent Genomic Alterations in Cyclin-Dependent Kinases Reveals Potential Therapeutic Strategies for Cancer Treatment

The kinase PDK1 is essential for B-cell receptor mediated survival signaling

Nuclear Factor-κB Modulates Regulatory T Cell Development by Directly Regulating Expression of Foxp3 Transcription Factor

Factors Affecting the Cancer Immunotherapeutic Efficacy of T Cell Bispecific Antibodies and Strategies for Improvement

Ibrutinib treatment improves T cell number and function in CLL patients

Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia

CD33‐Targeted Therapies: Beating the Disease or Beaten to Death?

A CD3 humanized mouse model unmasked unique features of T-cell responses to bispecific antibody treatment

IκBβ acts to inhibit and activate gene expression during the inflammatory response

T Regulatory Cells Maintain Intestinal Homeostasis by Suppressing γδ T Cells

The IKK-neutralizing compound Bay11 kills supereffector CD8 T cells by altering caspase-dependent activation-induced cell death

Trial in Progress: Phase 1/2 Study Evaluating the Safety and Efficacy of Iov-2001, an Autologous, Non-Genetically Modified, Polyclonal T-Cell Product, in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Expansion and Characterization of Iovance Marrow Infiltrating Lymphocytes: A Potential Novel Therapeutic Strategy for the Treatment of Acute Myeloid Leukemia

Abstract CT244: A Phase 1/2 study evaluating the safety and efficacy of IOV-2001 in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)

PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression

Systematic Pan-Cancer Characterization of Nuclear Receptors Identifies Potential Cancer Biomarkers and Therapeutic Targets

SUSD2 suppresses CD8 + T cell antitumor immunity by targeting IL-2 receptor signaling

A Phase 1 Study of Plamotamab, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma: Recommended Dose Safety/Efficacy Update and Escalation Exposure-Response Analysis

Suchergebnisse filtern